CFON-026
CFON-026 is a selective, orally active and non-covalent BTK inhibitor with an IC50 of 0.27 nM. CFON-026 has significant antitumor activity against wild-type BTK (TMD8 and REC-1) and all clinically relevant BTK resistance mutations (BTK C481S, T474I, L528W and V416L). CFON-026 induces complete tumor regression in TMD8 xenograft mice model. CFON-026 can be used for research of hematological cancers like chronic lymphocytic leukemia and waldenström macroglobulinemia.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2941611-57-8
- Fòrmula: C33H34N8O2
- Peso molecular:574.68
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
CFON-026 exhibits significant anti-proliferative activity against BTK-dependent cell lines TMD8 and REC-1, with IC50 values of 0.45 and 1.7 nM respectively. It maintains nanomolar-level potent inhibition against cells with endogenous BTK resistance mutations (C481S, V416L, T474I, L528W, M437R)[1][2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2941611-57-8
-
Peso molecular 574.68
-
Fòrmula C33H34N8O2
-
SMILES
NC1=NC=C2/C=C/CCCCCC(N[C@@H]3CCC[C@@H](C4=NC(C5=CC=C(C(NC6=CC(C#N)=CC=N6)=O)C=C5)=C1N24)C3)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CFON-026 Related Classifications
HY-174850 Related Classifications
Powered by Bioz